Leerink Partnrs Research Analysts Cut Earnings Estimates for Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Leerink Partnrs dropped their Q2 2024 earnings per share (EPS) estimates for Acadia Healthcare in a note issued to investors on Thursday, May 2nd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.92 per share for the quarter, down from their prior forecast of $0.96. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.56 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q3 2024 earnings at $0.98 EPS, Q4 2024 earnings at $0.86 EPS, FY2024 earnings at $3.59 EPS, Q1 2025 earnings at $0.89 EPS, Q2 2025 earnings at $1.04 EPS, Q3 2025 earnings at $1.09 EPS, Q4 2025 earnings at $0.97 EPS, FY2025 earnings at $4.00 EPS, FY2026 earnings at $4.61 EPS and FY2027 earnings at $5.31 EPS.

ACHC has been the subject of several other research reports. UBS Group increased their price target on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. Mizuho dropped their target price on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. TheStreet upgraded Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Finally, Barclays reduced their price objective on shares of Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a research report on Thursday, May 2nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $88.89.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $67.43 on Monday. The business’s 50-day moving average price is $76.02 and its 200-day moving average price is $77.40. The firm has a market capitalization of $6.26 billion, a price-to-earnings ratio of -481.61, a PEG ratio of 1.96 and a beta of 1.31. Acadia Healthcare has a 12 month low of $64.74 and a 12 month high of $87.77. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The firm’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.75 EPS.

Insiders Place Their Bets

In other news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 2.00% of the company’s stock.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the company. Fifth Third Bancorp boosted its position in shares of Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after acquiring an additional 136 shares during the last quarter. Estate Counselors LLC boosted its holdings in shares of Acadia Healthcare by 0.9% in the 3rd quarter. Estate Counselors LLC now owns 16,410 shares of the company’s stock worth $1,154,000 after purchasing an additional 145 shares in the last quarter. Tranquility Partners LLC raised its holdings in shares of Acadia Healthcare by 5.3% during the 4th quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock valued at $264,000 after buying an additional 170 shares in the last quarter. Mackenzie Financial Corp lifted its position in Acadia Healthcare by 1.3% in the 3rd quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock worth $1,063,000 after buying an additional 199 shares during the last quarter. Finally, New York State Teachers Retirement System raised its stake in shares of Acadia Healthcare by 0.3% during the first quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock worth $6,025,000 after acquiring an additional 200 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.